GARP on hepatic stellate cells is essential for the development of liver fibrosis

被引:13
作者
Zhang, Xiaolong [1 ]
Sharma, Pankaj [1 ]
Maschmeyer, Patrick [1 ]
Hu, Yu [1 ]
Lou, Mumeng [1 ]
Kim, Jessica [1 ]
Fujii, Hodaka [2 ]
Unutmaz, Derya [3 ]
Schwabe, Robert F. [4 ]
Winau, Florian [1 ,5 ]
机构
[1] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Program Cellular & Mol Med, Boston, MA USA
[2] Hirosaki Univ, Grad Sch Med, Dept Biochem & Genome Biol, Hirosaki, Aomori, Japan
[3] Jackson Lab Genom Med, Farmington, CT USA
[4] Columbia Univ, Inst Human Nutr, Coll Phys & Surg, Dept Med, New York, NY USA
[5] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, 200 Longwood Ave, Boston, MA 02115 USA
关键词
GARP; hepatic stellate cells (HSCs); liver fibrosis; TGF-I3; natural killer T (NKT) cells; endothelin-1 (ET-1); LATENT TGF-BETA; T-CELLS; RECEPTOR ANTAGONIST; ENDOTHELIN; TGF-BETA-1; INFLAMMATION; EXPRESSION; ACCUMULATION; ACTIVATION; MECHANISMS;
D O I
10.1016/j.jhep.2023.05.043
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Glycoprotein A repetitions predominant (GARP) is a membrane protein that functions as a latent TGF-I3 docking molecule. While the immune regulatory properties of GARP on blood cells have been studied, the function of GARP on tissue stromal cells remains unclear. Here, we investigate the role of GARP expressed on hepatic stellate cells (HSCs) in the development of liver fibrosis. Methods: The function of GARP on HSCs was explored in toxin-induced and metabolic liver fibrosis models, using conditional GARP-deficient mice or a newly generated inducible system for HSC-specific gene ablation. Primary mouse and human HSCs were isolated to evaluate the contribution of GARP to the activation of latent TGF-I3. Moreover, cell contraction of HSCs in the context of TGF-I3 activation was tested in a GARP-dependent fashion. Results: Mice lacking GARP in HSCs were protected from developing liver fibrosis. Therapeutically deleting GARP on HSCs alleviated the fibrotic process in established disease. Furthermore, natural killer T cells exacerbated hepatic fibrosis by inducing GARP expression on HSCs through IL-4 production. Mechanistically, GARP facilitated fibrogenesis by activating TGF-I3 and enhancing endothelin-1-mediated HSC contraction. Functional GARP was expressed on human HSCs and significantly upre-gulated in the livers of patients with fibrosis. Lastly, deletion of GARP on HSCs did not augment inflammation or liver damage. Conclusions: GARP expressed on HSCs drives the development of liver fibrosis via cell contraction-mediated activation of latent TGF-I3. Considering that systemic blockade of TGF-I3 has major side effects, we highlight a therapeutic niche provided by GARP and surface-mediated TGF-I3 activation. Thus, our findings suggest an important role of GARP on HSCs as a promising target for the treatment of liver fibrosis.(c) 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1214 / 1225
页数:13
相关论文
共 50 条
[21]   Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC [J].
Melhem, Alaa ;
Muhanna, Nidal ;
Bishara, Amal ;
Alvarez, Carlos E. ;
Ilan, Yaron ;
Bishara, Taiser ;
Horani, Amjad ;
Nassar, Mithal ;
Friedman, Scott L. ;
Safadi, Rifaat .
JOURNAL OF HEPATOLOGY, 2006, 45 (01) :60-71
[22]   Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer [J].
Metelli, Alessandra ;
Salem, Mohammad ;
Wallace, Caroline H. ;
Wu, Bill X. ;
Li, Anqi ;
Li, Xue ;
Li, Zihai .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
[23]   A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells [J].
Miyamoto, K ;
Miyake, S ;
Yamamura, T .
NATURE, 2001, 413 (6855) :531-534
[24]   The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells [J].
Oki, S ;
Chiba, A ;
Yamamura, T ;
Miyake, S .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (11) :1631-1640
[25]   Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells [J].
Pinzani, M ;
Milani, S ;
DeFranco, R ;
Grappone, C ;
Caligiuri, A ;
Gentilini, A ;
TostiGuerra, C ;
Maggi, M ;
Failli, P ;
Ruocco, C ;
Gentilini, P .
GASTROENTEROLOGY, 1996, 110 (02) :534-548
[26]   Platelets subvert T cell immunity against cancer via GARP-TGFβ axis [J].
Rachidi, Saleh ;
Metelli, Alessandra ;
Riesenberg, Brian ;
Wu, Bill X. ;
Nelson, Michelle H. ;
Wallace, Caroline ;
Paulos, Chrystal M. ;
Rubinstein, Mark P. ;
Garrett-Mayer, Elizabeth ;
Hennig, Mirko ;
Bearden, Daniel W. ;
Yang, Yi ;
Liu, Bei ;
Li, Zihai .
SCIENCE IMMUNOLOGY, 2017, 2 (11)
[27]   Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners [J].
Radaeva, S ;
Sun, R ;
Jaruga, B ;
Nguyen, VT ;
Tian, ZG ;
Gao, B .
GASTROENTEROLOGY, 2006, 130 (02) :435-452
[28]   Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins [J].
Robertson, Ian B. ;
Rifkin, Daniel B. .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2016, 8 (06)
[29]   Endothelin antagonism in experimental hepatic fibrosis - Implications for endothelin in the pathogenesis of wound healing [J].
Rockey, DC ;
Chung, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (06) :1381-1388
[30]   CHARACTERIZATION OF ENDOTHELIN RECEPTORS MEDIATING RAT HEPATIC STELLATE CELL CONTRACTION [J].
ROCKEY, DC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 207 (02) :725-731